Nuveen LLC Takes $1.24 Million Position in SelectQuote, Inc. $SLQT

Key Points

• Nuveen LLC has invested approximately $1.24 million in SelectQuote, acquiring 370,796 shares of the company's stock, which represents 0.22% ownership.
• SelectQuote reported a quarterly earnings per share (EPS) of ($0.17), surpassing analysts' expectations of ($0.18), with a revenue of $345.10 million for the quarter.
• Analysts hold a mixed view on SelectQuote, with an average rating of "Hold" and a consensus price target of $4.42.

Nuveen LLC acquired a new stake in shares of SelectQuote, Inc. (NYSE:SLQT - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 370,796 shares of the company's stock, valued at approximately $1,238,000. Nuveen LLC owned 0.22% of SelectQuote as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also added to or reduced their stakes in the company. Aigen Investment Management LP purchased a new position in shares of SelectQuote during the first quarter valued at about $50,000. Virtu Financial LLC purchased a new stake in SelectQuote in the first quarter worth approximately $34,000. Invesco Ltd. grew its position in SelectQuote by 6.7% in the 1st quarter. Invesco Ltd. now owns 240,372 shares of the company's stock worth $803,000 after purchasing an additional 15,079 shares during the period. Connor Clark & Lunn Investment Management Ltd. raised its stake in SelectQuote by 62.0% during the 1st quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,251,828 shares of the company's stock valued at $4,181,000 after buying an additional 478,997 shares during the last quarter. Finally, Swiss National Bank bought a new position in shares of SelectQuote during the 1st quarter valued at $888,000. 34.59% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

SLQT has been the subject of several research analyst reports. Zacks Research lowered SelectQuote from a "hold" rating to a "strong sell" rating in a report on Wednesday, August 27th. Wall Street Zen cut SelectQuote from a "buy" rating to a "hold" rating in a report on Sunday, June 22nd. Royal Bank Of Canada reduced their price target on SelectQuote from $7.00 to $6.00 and set a "sector perform" rating for the company in a research report on Tuesday, August 5th. Finally, Jefferies Financial Group initiated coverage on SelectQuote in a research note on Wednesday, May 21st. They set a "hold" rating and a $2.75 price objective for the company. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $4.42.

SelectQuote Stock Performance

Shares of SelectQuote stock traded down $0.11 during trading hours on Tuesday, hitting $2.16. The company's stock had a trading volume of 1,426,181 shares, compared to its average volume of 2,716,610. The company has a debt-to-equity ratio of 0.90, a current ratio of 5.68 and a quick ratio of 5.68. The business has a 50 day moving average price of $2.17 and a two-hundred day moving average price of $2.81. SelectQuote, Inc. has a 12-month low of $1.62 and a 12-month high of $6.86.

SelectQuote (NYSE:SLQT - Get Free Report) last issued its earnings results on Thursday, August 21st. The company reported ($0.17) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.18) by $0.01. SelectQuote had a return on equity of 6.35% and a net margin of 3.12%.The company had revenue of $345.10 million for the quarter, compared to the consensus estimate of $334.09 million. SelectQuote has set its FY 2026 guidance at EPS. As a group, equities analysts forecast that SelectQuote, Inc. will post -0.07 EPS for the current fiscal year.

SelectQuote Profile

SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.